Matches in SemOpenAlex for { <https://semopenalex.org/work/W2011426512> ?p ?o ?g. }
- W2011426512 endingPage "832" @default.
- W2011426512 startingPage "826" @default.
- W2011426512 abstract "Efficacy and safety of ketanserin were studied prospectively in a randomized, double-blind trial involving 221 patients treated for hypertension or coronary artery disease, or both. Since ketanserin has been suggested to cause QTc prolongation, the incidence and severity of this effect were investigated, as was the incidence of malignant ventricular arrhythmias during Holter monitoring. After a 1-week run-in period, all patients were examined: blood pressure was measured and electrocardiograms and 24-hour Holter electrocardiograms were obtained. Two thirds of the patients (n = 147) were then randomized to receive ketanserin for 1 week (20 mg twice daily) followed by 3 weeks of 40 mg twice daily; one third of the patients (n = 74) received placebo (twice daily) for 4 weeks. After 4 weeks of treatment, blood pressure, electrocardiograms and 24-hour Holter electrocardiograms were repeated. In hypertensive patients, ketanserin significantly reduced systolic (mean reduction 17 +/- 2 mm Hg, p less than 0.0001) and diastolic blood pressure (12 +/- 1 mm Hg, p less than 0.0001) compared to baseline, and to the placebo group (p less than 0.005 for systolic and diastolic blood pressure). The QTc interval was prolonged with ketanserin (mean 400 to 418 ms, p less than 0.01) but not with placebo (399 vs 402 ms). In the ketanserin group 30% of patients and in the placebo group 8% of patients had QTc prolongation greater than 30 ms (p less than 0.01).(ABSTRACT TRUNCATED AT 250 WORDS)" @default.
- W2011426512 created "2016-06-24" @default.
- W2011426512 creator A5007118900 @default.
- W2011426512 creator A5008206072 @default.
- W2011426512 creator A5009430890 @default.
- W2011426512 creator A5023929872 @default.
- W2011426512 creator A5031080698 @default.
- W2011426512 creator A5058985726 @default.
- W2011426512 creator A5079016754 @default.
- W2011426512 date "1989-04-01" @default.
- W2011426512 modified "2023-10-16" @default.
- W2011426512 title "Incidence and clinical relevance of QT prolongation caused by the new selective serotonin antagonist ketanserin" @default.
- W2011426512 cites W1985520043 @default.
- W2011426512 cites W2006501433 @default.
- W2011426512 cites W2008768823 @default.
- W2011426512 cites W2026508775 @default.
- W2011426512 cites W2044111220 @default.
- W2011426512 cites W2048898332 @default.
- W2011426512 cites W2057757465 @default.
- W2011426512 cites W2066613754 @default.
- W2011426512 cites W2094146267 @default.
- W2011426512 cites W2121173726 @default.
- W2011426512 cites W2506892628 @default.
- W2011426512 cites W4210564831 @default.
- W2011426512 cites W4213200229 @default.
- W2011426512 cites W4232519186 @default.
- W2011426512 cites W4235518199 @default.
- W2011426512 cites W4236727386 @default.
- W2011426512 cites W4242068985 @default.
- W2011426512 cites W4244698894 @default.
- W2011426512 cites W4245864593 @default.
- W2011426512 cites W4252869013 @default.
- W2011426512 doi "https://doi.org/10.1016/0002-9149(89)90051-9" @default.
- W2011426512 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2648788" @default.
- W2011426512 hasPublicationYear "1989" @default.
- W2011426512 type Work @default.
- W2011426512 sameAs 2011426512 @default.
- W2011426512 citedByCount "32" @default.
- W2011426512 countsByYear W20114265122013 @default.
- W2011426512 countsByYear W20114265122022 @default.
- W2011426512 crossrefType "journal-article" @default.
- W2011426512 hasAuthorship W2011426512A5007118900 @default.
- W2011426512 hasAuthorship W2011426512A5008206072 @default.
- W2011426512 hasAuthorship W2011426512A5009430890 @default.
- W2011426512 hasAuthorship W2011426512A5023929872 @default.
- W2011426512 hasAuthorship W2011426512A5031080698 @default.
- W2011426512 hasAuthorship W2011426512A5058985726 @default.
- W2011426512 hasAuthorship W2011426512A5079016754 @default.
- W2011426512 hasConcept C118441451 @default.
- W2011426512 hasConcept C120665830 @default.
- W2011426512 hasConcept C121332964 @default.
- W2011426512 hasConcept C126322002 @default.
- W2011426512 hasConcept C142724271 @default.
- W2011426512 hasConcept C164705383 @default.
- W2011426512 hasConcept C170493617 @default.
- W2011426512 hasConcept C204787440 @default.
- W2011426512 hasConcept C27081682 @default.
- W2011426512 hasConcept C2775864247 @default.
- W2011426512 hasConcept C2777785214 @default.
- W2011426512 hasConcept C2777953023 @default.
- W2011426512 hasConcept C42219234 @default.
- W2011426512 hasConcept C53910766 @default.
- W2011426512 hasConcept C57900726 @default.
- W2011426512 hasConcept C61511704 @default.
- W2011426512 hasConcept C71924100 @default.
- W2011426512 hasConcept C84393581 @default.
- W2011426512 hasConceptScore W2011426512C118441451 @default.
- W2011426512 hasConceptScore W2011426512C120665830 @default.
- W2011426512 hasConceptScore W2011426512C121332964 @default.
- W2011426512 hasConceptScore W2011426512C126322002 @default.
- W2011426512 hasConceptScore W2011426512C142724271 @default.
- W2011426512 hasConceptScore W2011426512C164705383 @default.
- W2011426512 hasConceptScore W2011426512C170493617 @default.
- W2011426512 hasConceptScore W2011426512C204787440 @default.
- W2011426512 hasConceptScore W2011426512C27081682 @default.
- W2011426512 hasConceptScore W2011426512C2775864247 @default.
- W2011426512 hasConceptScore W2011426512C2777785214 @default.
- W2011426512 hasConceptScore W2011426512C2777953023 @default.
- W2011426512 hasConceptScore W2011426512C42219234 @default.
- W2011426512 hasConceptScore W2011426512C53910766 @default.
- W2011426512 hasConceptScore W2011426512C57900726 @default.
- W2011426512 hasConceptScore W2011426512C61511704 @default.
- W2011426512 hasConceptScore W2011426512C71924100 @default.
- W2011426512 hasConceptScore W2011426512C84393581 @default.
- W2011426512 hasIssue "12" @default.
- W2011426512 hasLocation W20114265121 @default.
- W2011426512 hasLocation W20114265122 @default.
- W2011426512 hasOpenAccess W2011426512 @default.
- W2011426512 hasPrimaryLocation W20114265121 @default.
- W2011426512 hasRelatedWork W2046249837 @default.
- W2011426512 hasRelatedWork W2099993889 @default.
- W2011426512 hasRelatedWork W2135427367 @default.
- W2011426512 hasRelatedWork W2156217449 @default.
- W2011426512 hasRelatedWork W2365792327 @default.
- W2011426512 hasRelatedWork W2400744536 @default.
- W2011426512 hasRelatedWork W2403270105 @default.
- W2011426512 hasRelatedWork W3037700283 @default.
- W2011426512 hasRelatedWork W47949814 @default.